Cargando…
OxLDL/β2GPI/anti-β2GPI Ab complex induces inflammatory activation via the TLR4/NF-κB pathway in HUVECs
Patients with antiphospholipid syndrome have been identified to have higher incidence rates of atherosclerosis (AS) due to the elevated levels of anti-β2-glycoprotein I (β2GPI) antibody (Ab). Our previous studies revealed that the anti-β2GPI Ab formed a stable oxidized low-density lipoprotein (oxLDL...
Autores principales: | Zhang, Guiting, Cai, Qianqian, Zhou, Hong, He, Chao, Chen, Yudan, Zhang, Peng, Wang, Ting, Xu, Liangjie, Yan, Jinchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789093/ https://www.ncbi.nlm.nih.gov/pubmed/33355374 http://dx.doi.org/10.3892/mmr.2020.11787 |
Ejemplares similares
-
Impaired Autophagy Induced by oxLDL/β2GPI/anti-β2GPI Complex through PI3K/AKT/mTOR and eNOS Signaling Pathways Contributes to Endothelial Cell Dysfunction
por: Zhang, Guiting, et al.
Publicado: (2021) -
Pro-atherogenic activation of A7r5 cells induced by the oxLDL/β(2)GPI/anti-β(2)GPI complex
por: Wang, Ting, et al.
Publicado: (2018) -
Correlation Between Serum β2-GPI/oxLDL and the Risk of Cerebral Infarction in Patients with T2DM
por: Kuang, Wending, et al.
Publicado: (2022) -
Predictive Value of Oxidized Low-Density Lipoprotein/β(2)-Glycoprotein-I Complexes (oxLDL/β(2)GPI) in Nonautoimmune Atherothrombosis
por: Ames, Paul R. J., et al.
Publicado: (2018) -
TET2 Protects against oxLDL-Induced HUVEC Dysfunction by Upregulating the CSE/H(2)S System
por: Peng, Juan, et al.
Publicado: (2017)